HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nethaji Muniraj Selected Research

Nethaji Muniraj Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 08/2017
7Breast Neoplasms (Breast Cancer)
08/2021 - 08/2017
3Carcinogenesis
01/2021 - 08/2017
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Obesity
08/2021
1Hepatocellular Carcinoma (Hepatoma)
03/2019
1Inflammation (Inflammations)
03/2019
1Rheumatic Diseases (Rheumatism)
02/2017
1Endometrial Neoplasms (Endometrial Cancer)
09/2010
1Carcinoma (Carcinomatosis)
10/2009

Drug/Important Bio-Agent (IBA)

2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2021 - 10/2019
2Biological ProductsIBA
01/2021 - 10/2019
2withaferin AIBA
03/2019 - 01/2019
1AntigensIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
01/2022
1Carboplatin (JM8)FDA LinkGeneric
12/2021
1GANT 61IBA
12/2021
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2021
1Hormones (Hormone)IBA
08/2021
1Phenobarbital (Luminal)FDA Link
08/2021
1TamoxifenFDA LinkGeneric
08/2021
1LeptinIBA
08/2021
1CateninsIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2020
1honokiolIBA
01/2020
1Chloroquine (Aralen)FDA LinkGeneric
01/2020
1Etoposide (VP 16)FDA LinkGeneric
10/2019
1SilverIBA
10/2019
1Vinblastine (Vinblastine Sulfate)FDA Link
10/2019
1Vincristine (Oncovin)FDA LinkGeneric
10/2019
1Pharmaceutical PreparationsIBA
10/2019
1Paclitaxel (Taxol)FDA LinkGeneric
10/2019
1Histone Deacetylase InhibitorsIBA
03/2019
1ChemokinesIBA
03/2019
1CytokinesIBA
03/2019
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2019
1LactonesIBA
01/2019
1PhosphoproteinsIBA
10/2017
1benzyl isothiocyanateIBA
10/2017
1AdipokinesIBA
08/2017
1Phosphotransferases (Kinase)IBA
08/2017
1AdiponectinIBA
08/2017
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
02/2017
1Protein Isoforms (Isoforms)IBA
09/2010
1Human Growth Hormone (Saizen)FDA LinkGeneric
09/2010
1Trefoil Factor-1IBA
10/2009

Therapy/Procedure

8Therapeutics
01/2022 - 10/2017
2Drug Therapy (Chemotherapy)
01/2022 - 08/2017
1Immunotherapy
01/2022
1Aftercare (After-Treatment)
03/2019